A protein-based therapeutic for human cytomegalovirus infection

François Jean, Laurel Thomas, Sean S. Molloy, Gseping Liu, Michael A. Jarvis, Jay Nelson, Gary Thomas

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, α1-PDX. This protein is a potent and selective furin inhibitor (K(i) = 0.6 nM) and is 10- fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad- based anti-pathogens.

Original languageEnglish (US)
Pages (from-to)2864-2869
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number6
DOIs
StatePublished - Mar 14 2000

Fingerprint

Furin
Cytomegalovirus Infections
Proteins
Serpins
Bacterial Toxins
Virus Activation
Viral Proteins
Therapeutics
Cytomegalovirus
Serine
Antiviral Agents
Glycoproteins
Cell Culture Techniques
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A protein-based therapeutic for human cytomegalovirus infection. / Jean, François; Thomas, Laurel; Molloy, Sean S.; Liu, Gseping; Jarvis, Michael A.; Nelson, Jay; Thomas, Gary.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 6, 14.03.2000, p. 2864-2869.

Research output: Contribution to journalArticle

Jean, François ; Thomas, Laurel ; Molloy, Sean S. ; Liu, Gseping ; Jarvis, Michael A. ; Nelson, Jay ; Thomas, Gary. / A protein-based therapeutic for human cytomegalovirus infection. In: Proceedings of the National Academy of Sciences of the United States of America. 2000 ; Vol. 97, No. 6. pp. 2864-2869.
@article{8e22a53c429a4aaeb1db94c528d88d35,
title = "A protein-based therapeutic for human cytomegalovirus infection",
abstract = "Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, α1-PDX. This protein is a potent and selective furin inhibitor (K(i) = 0.6 nM) and is 10- fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad- based anti-pathogens.",
author = "Fran{\cc}ois Jean and Laurel Thomas and Molloy, {Sean S.} and Gseping Liu and Jarvis, {Michael A.} and Jay Nelson and Gary Thomas",
year = "2000",
month = "3",
day = "14",
doi = "10.1073/pnas.050504297",
language = "English (US)",
volume = "97",
pages = "2864--2869",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - A protein-based therapeutic for human cytomegalovirus infection

AU - Jean, François

AU - Thomas, Laurel

AU - Molloy, Sean S.

AU - Liu, Gseping

AU - Jarvis, Michael A.

AU - Nelson, Jay

AU - Thomas, Gary

PY - 2000/3/14

Y1 - 2000/3/14

N2 - Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, α1-PDX. This protein is a potent and selective furin inhibitor (K(i) = 0.6 nM) and is 10- fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad- based anti-pathogens.

AB - Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, α1-PDX. This protein is a potent and selective furin inhibitor (K(i) = 0.6 nM) and is 10- fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad- based anti-pathogens.

UR - http://www.scopus.com/inward/record.url?scp=0034646199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034646199&partnerID=8YFLogxK

U2 - 10.1073/pnas.050504297

DO - 10.1073/pnas.050504297

M3 - Article

C2 - 10681468

AN - SCOPUS:0034646199

VL - 97

SP - 2864

EP - 2869

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -